3 Key Takeaways from SCOPE Summit 2024

This year’s SCOPE Summit in Orlando convened over 3,500 specialists across pharma, biotech, research, and solutions to share insights in advancing clinical efforts within the life science industry. 

‍

Our Egnyte life science experts were on site, and here are a few key takeaways from our experience at this year's summit:

‍

Expanding Trial Access Through Inclusive Recruitment

This year, there was dialogue from multiple life science experts in exploring how AI-enhanced patient matching can address recruitment pain points. Prioritizing representative enrollment signals progress in vetting treatments against diverse populations with recruitment technologies that can help overcome participation barriers. As personalized therapeutics demand niche cohorts, AI promises equitable patient recruitment at scale.

‍

Aligning Sites and Sponsors With Collaboration Tools

Surging site networking indicates un- or under-tapped interest in facilitating trials. Sites’ proactive involvement and infrastructure readiness signal the potential to accelerate studies when paired with sponsors through efficient collaboration tools for secure, streamlined content sharing. This creates an environment where solutions such as Egnyte for Life Science can aid in meeting drug development timelines with clinical content collaboration tools to bridge sites and sponsors securely.

‍

Modular Software Simplifies Specific Needs

While some providers offer end-to-end systems, emerging biotechs want configurable point solutions. The prominence of standalone eTMF offerings proves mastering documentation remains challenging. This suggests that eTMF management is still a significant pain point for clinical trial sponsors and CROs. The market is ripe for disruption, particularly among emerging biotechs that are less likely to go all-in on a single provider for all their technology needs. Egnyte can meet this demand with secure clinical content controls while enabling budget-conscious software customization.

‍

Conclusion

SCOPE Summit 2024 was a great opportunity for us to explore the industry’s most pressing needs in meeting drug development timelines. From clinical giants to emerging biotechs, players in this industry are ready to accelerate their trials through secure, configurable technology built for the unique complexities of the life science industry. 

‍

Interested in learning more about Egnyte and connecting with our life science experts? Check out our 15-day free trial of Egnyte for Life Sciences to see our Secure Collaborative Platform in action.

‍